Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

David Mowry Biography and Net Worth

CEO of Cutera

David H. Mowry has 29 years of experience in the Medical Device industry across multiple market segments and serves as Cutera’s Chief Executive Officer and member of Cutera’s board of directors.

Previous to Cutera, Dave served as the President and Chief Executive Officer for Vyaire Medical, recognized leader in respiratory diagnostics, ventilation, and airway management solutions. Prior to Vyaire, Dave served from October 2015 to May 2016 as Executive Vice President, Chief Operating Officer and member of the board of directors for Wright Medical Group N.V. (Nasdaq: WMGI), a global medical device company focused on extremities and biologics products. Prior to Wright Medical Group, Mr. Mowry served as President and Chief Executive Officer and member of the board of directors of Tornier N.V. from February 2013 until October 2015, at which time Tornier and Wright Medical Group merged, Prior to his assignment as Tornier’s CEO, Dave has held executive leadership positions at Covidien plc, ev3, Inc. and Zimmer Spine, Inc. Dave received a B.S. in Engineering from the United States Military Academy at West Point.

What is David H. Mowry's net worth?: The estimated net worth of David H. Mowry is at least $35,890.02 as of September 11th, 2023. Mr. Mowry owns 92,381 shares of Cutera stock worth more than $35,890 as of November 8th. This net worth evaluation does not reflect any other assets that Mr. Mowry may own. Learn More about David H. Mowry's net worth.
How do I contact David H. Mowry?: The corporate mailing address for Mr. Mowry and other Cutera executives is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. Cutera can also be reached via phone at (415) 657-5500 and via email at [email protected]. Learn More on David H. Mowry's contact information.
Has David H. Mowry been buying or selling shares of Cutera?: David H. Mowry has not been actively trading shares of Cutera in the last ninety days. Most recently, on Friday, May 13th, David H. Mowry bought 996 shares of Cutera stock. The stock was acquired at an average cost of $50.12 per share, with a total value of $49,919.52. Following the completion of the transaction, the chief executive officer now directly owns 131,779 shares of the company's stock, valued at $6,604,763.48. Learn More on David H. Mowry's trading history.
Who are Cutera's active insiders?: Cutera's insider roster includes David Mowry (CEO), Timothy Oshea (Director), J. Plants (Director), Rohan Seth (CFO), Joseph Whitters (Director), and Katherine Zanotti (Director). Learn More on Cutera's active insiders.
Are insiders buying or selling shares of Cutera?: During the last year, insiders at the medical device company sold shares 2 times. They sold a total of 35,788 shares worth more than $91,172.20. The most recent insider tranaction occured on May, 16th when EVP Michael Karavitis sold 24,940 shares worth more than $64,594.60. Insiders at Cutera own 0.4% of the company. Learn More about insider trades at Cutera.
Information on this page was last updated on 5/16/2024.

David H. Mowry Insider Trading History at Cutera

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/13/2022	Buy	996	$50.12	$49,919.52	131,779
3/4/2022	Buy	2,453	$40.81	$100,106.93
12/6/2021	Buy	1,417	$35.15	$49,807.55
12/1/2021	Buy	2,784	$35.91	$99,973.44
3/10/2020	Buy	5,200	$18.11	$94,172.00

David H. Mowry Buying and Selling Activity at Cutera

Cutera Company Overview

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Today's Range

Now: $0.39

$0.36

$0.51

50 Day Range

MA: $0.70

$0.51

$0.82

2 Week Range

Now: $0.39

$0.36

$4.97

Volume

2,127,622 shs

Average Volume

914,130 shs

Market Capitalization

$7.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

625,000% Gain

From Crypto Swap Profits | Ad

>> Dive into the Workshop Here